We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cochlear Implant Aids the Profoundly Deaf

By HospiMedica staff writers
Posted on 02 Mar 2006
A ribbon-like cochlear implant could greatly improve hearing for profoundly deaf patients and also simplify insertion, helping surgeons minimize damage to healthy ear tissue. More...


A team at the University of Michigan (Ann Arbor, MI, USA) made the implant and embedded thin-film electrode sites that directly stimulate the auditory nerve. The implant is currently being tested in guinea pigs and cats, said team leader Kensall D. Wise, director of the Center for Wireless Integrated Microsystems (WIMS, Ann Arbor, MI, USA), who also holds appointments in the departments of biomedical engineering, electrical engineering, and computer science at the university. The device may be available in four to five years for use in humans.

Approximately 100,000 patients to date have received cochlear implants worldwide. The current technology, Dr. Wise noted, is bulky, difficult for surgeons to insert, and does not allow a great range of perceived frequencies. The present implants use electrodes formed from a bundle of wires fed into the snail-shaped cochlea of the inner ear, and each implant has anywhere from 16 to 22 stimulating sites along its length. By contrast, the new implant will host up to 128 stimulating sites.

The range of frequencies that can be stimulated depends on how far into the cochlea the implant can go, with the lower frequencies located further up toward the apex of the spiral canal, said Dr. Wise. More sites mean greater tonal range and better frequency perception, and the implant's flexibility will minimize damage to existing hearing.

The ribbon film technology lets researchers embed other functions in the implant, such as position sensors that allow surgeons to watch the implant's progress on a monitor as they are feeding it into the cochlea. The implant can be manufactured by the same process used in making integrated circuits, which means it can be mass produced.



Related Links:
University of Michigan

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Hypodermic Syringe
SurTract™ Safety Syringe
New
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.